Inve India ▾

OSEL Devices share price & results

OSEL Devices· Healthcare

Results to
Mar 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

Delhi-headquartered multi-vertical Indian electronics and medtech maker of LED displays, hearing aids and Philips-licensed mobile phones, built design-to-delivery from its Greater Noida facility.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue146 ₹ crore+47.5% YoYQuarterly, as filedQuarter to Mar 2026Revenue from operations as filed.
Operating margin20.0 %0.0 pts YoYOperating profit / revenueQuarter to Mar 2026For the quarter; a change is in percentage points.
Net profit14.0 ₹ crore+16.7% YoYQuarterly, as filedQuarter to Mar 2026Profit after tax as filed.
Return on equityUnavailable+0.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin-12.29 %+24.9 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable—Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Mar 2026

Guidance

What management said, and what became of it

2 of 5 judged targets kept · 6 open · verdicts reflect calls analysed to Q4 FY26.

OSEL Devices management guidance track record on Inve: 11 targets tracked across analysed earnings calls (2 achieved, 3 missed, 6 open).

TargetOriginal wordingSaidLatest callVerdict
Overall Revenue Growth25% CAGR for both the divisions
Call transcript, Q4 FY25 · 27 May 2025		Q4 FY25Q4 FY26:Achieved 56.9% YoY revenue growth for FY26, significantly exceeding both the original and diluted targets.
Call transcript, Q4 FY26 · 2 Jun 2026		Achieved
Receivable Days as % of Salesremain to around 30%-35% for next year
Call transcript, Q4 FY25 · 27 May 2025		Q4 FY25Q4 FY26:No data provided on receivable days for FY26 in the year-end earnings call. The deadline to verify this promise has passed.
Call transcript, Q4 FY26 · 2 Jun 2026		Ghosted
Smartphone Launchby this year end, I guess we should have it
Call transcript, Q4 FY25 · 27 May 2025		Q4 FY25Q4 FY26:Company 'successfully entered the smartphone market since March', a slight delay from the December 2025 target for trial supplies.
Call transcript, Q4 FY26 · 2 Jun 2026		Delayed

Source: Inve Guidance Tracker for OSEL Devices · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

3 of OSEL Devices's 11 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 8 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹336.4 +0.06% · +₹0.2

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −41.9% 1Y

₹300₹400₹500₹600₹700₹800Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 13 Nov 2025Q4 FY26 — 2 Jun 2026

1Y: ₹578.55 on 24 Oct 2025 → ₹336.4. High ₹803.6 (20 Nov 2025), low ₹332 (22 Oct 2026).

Previous close
₹336.2
Market cap
₹587 Cr
52-week range
₹332 – ₹803.6
One year
−44.55%
Price to earnings (FY ending Mar 2026)
20.24×
Return on equity (FY ending Mar 2026)
18.59%

Overview

Symbol
NSE:OSELDEVICE
Exchange
NSE
Currency
INR

What OSEL Devices does

Based on the company's own presentations, annual report and earnings calls.

OSEL Devices designs, manufactures and installs LED display systems (indoor, outdoor, transparent and custom) for banking, retail, government, broadcast and education clients, and layers on a proprietary Digital Signage CMS platform for recurring subscription revenue. It also makes a full range of hearing aids (digital and rechargeable BTE, CIC and RIC) sold through government ADIP tenders, its own SFL audiologist clinics, white-label manufacturing and exports to the Middle East, Africa and the US. Since 2025 it has additionally been India's licensee for Philips-branded feature phones and, from March 2026, smartphones, manufactured under Make in India and sold through a distributor and retail network. Manufacturing, assembly, quality testing (USFDA/ISO/CDSCO/BIS-certified) and after-sales service for all three verticals run out of a single integrated facility in Greater Noida, UP.

Segments

  • LED Displays
  • Hearing Aids
  • Mobile Phones & Accessories
Operating verticals
3 (LED Displays, Hearing Aids, Mobile Phones & Accessories)
Manufacturing base
Single integrated facility in Greater Noida, Uttar Pradesh (design, assembly, QA and service under one roof)
Mobile-phone distribution network
268 distributors and 13,800+ retail touchpoints (H2 FY26)
Mobile-phone units shipped
4.55 lakh units (H2 FY26)
Regulatory/quality certifications
USFDA-registered facility; ISO 13485; ISO 9001; CDSCO MD-5; BIS (Visual Display Units & Hearing Aids); ZED Gold
Corporate group structure
4 subsidiaries — OSEL Healthcare, SFL Hearing Solutions (90.69% step-down, audiologist-staffed clinics), OSEL Industrial Park (proposed JNPA SEZ hub), Proxima Leasing (proposed)
Founded 2006Headquarters Delhi, India Company website

How the price took the results

close before → close after

Q4 FY26
+1.6%
2 Jun
Q2 FY26
+2.3%
13 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for OSEL Devices

Free account: one company. Everything above stays public.

Write why you follow OSEL Devices and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse OSEL Devices

Guides on how to read this kind of business and the numbers that matter.